NCT06257264 2026-04-22
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
Phase 1 Recruiting
BeOne Medicines
BeOne Medicines
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Olema Pharmaceuticals, Inc.
Pfizer
Syros Pharmaceuticals
Eli Lilly and Company
University of Wisconsin, Madison